Also PAR of all things?
Second rate anti-inflammatory that has the side effect of being an anticoagulant?!?
Marketed for osteoarthritis when that patient population is typically elderly, who have a high likelihood of being anticoagulated already. When it's not shown to be superior to current, non-anticoagulating anti-inflammatories?
Talking about shady investments hey?
This is going to plummet?, page-44
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.43 |
Change
0.080(3.40%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $2.39 | $2.44 | $2.37 | $2.750M | 1.137M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1924 | $2.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.44 | 16040 | 4 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |